WASHINGTON, Oct. 24 (UPI) -- The intravenous flu drug peramivir has received emergency approval for some hospitalized adults and children with H1N1, U.S. federal regulators said.
WASHINGTON, April 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
BIRMINGHAM, Ala., Jan. 4 (UPI) -- U.S. firm BioCryst said Thursday it has been awarded $102.6 million from the U.S. government to develop Peramivir for seasonal/pandemic flu.
BIRMINGHAM, Ala., Dec. 22 (UPI) -- BioCryst said Thursday it has launched a Phase I/II study of Fodosine to treat B-Cell acute lymphoblastic leukemia.
WASHINGTON, Dec. 22 (UPI) -- BioCryst said Thursday that it hss been cleared to begin testing its flu intravenous flu rememdy Peramivir.
NUTLEY, N.J., Nov. 30 (UPI) -- Roche and BioCryst said Wednesday they have teamed on a drug to prevent organ rejection and treat autoimmune disease.
WASHINGTON, Oct. 31 (UPI) -- Experts at the U.S. National Institutes of Health are testing the old drug Peramivir in shot form to see if it can work against the deadly avian flu strain.
REYKJAVIK, Iceland, Oct. 18 (UPI) -- Iceland's Actavis Group will pay $810 million to buy Alpharma Inc.'s generic drug business.
